These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3435692)

  • 41. Vitamin K and oral anticoagulant drugs as competitive antagonists in man.
    O'Reilly RA
    Pharmacology; 1972; 7(3):149-58. PubMed ID: 5054585
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypersensitivity to warfarin in rats with Walker 256 carcinoma.
    Owen CA
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):1-3. PubMed ID: 7063488
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of clotting factor biosynthesis by vitamin K.
    Suttie JW
    Fed Proc; 1969; 28(5):1696-701. PubMed ID: 4897771
    [No Abstract]   [Full Text] [Related]  

  • 45. Warfarin: effects on anticoagulant, hematologic, and blood enzyme values in normal ponies.
    Scott EA; Sandler GA; Byars TD
    Am J Vet Res; 1979 Jan; 40(1):142-6. PubMed ID: 453677
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the bioavailabilities and anticoagulant activities of two warfarin formulations.
    Stirling Y; Howarth DJ; Stockley R; Bland R; Towler CM; Harding SM
    Br J Haematol; 1982 May; 51(1):37-46. PubMed ID: 7073989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX, and X).
    Negrev NN; Radev RZ; Velikova MS; Anogeianaki A
    Int J Immunopathol Pharmacol; 2008; 21(1):221-6. PubMed ID: 18336749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of kinetic parameters for prothrombin complex activity during initiation of anticoagulation.
    Kuranari M; Hara M; Saikawa T; Kodama Y; Matsuo H; Sakata T; Takeyama M
    J Clin Pharm Ther; 1997; 22(5-6):347-51. PubMed ID: 19160719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Warfarin and vitamin K.
    Suttie JW
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI16-8. PubMed ID: 2191810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma level of vitamin K-dependent clotting factors as marker for hepatocellular carcinoma.
    Denninger MH; Degos F; Poilane I; Degott C; Benhamou JP; Guillin MC
    J Hepatol; 1991 Mar; 12(2):261-2. PubMed ID: 1646836
    [No Abstract]   [Full Text] [Related]  

  • 51. Interhospital Transfer Delays Anticoagulation Reversal in Warfarin-Associated Intracranial Hemorrhage.
    Zepeski A; Rewitzer S; Leira EC; Harland K; Faine BA
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3345-3349. PubMed ID: 30172677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy.
    Forestier F; Daffos F; Rainaut M; Solé Y; Amiral J
    Thromb Haemost; 1985 Jun; 53(3):401-3. PubMed ID: 3840288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simplified prothrombin time standardization.
    Talstad I; Korsbrekke K
    Haemostasis; 1994; 24(1):4-13. PubMed ID: 7959355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age as a determinant of sensitivity to warfarin.
    Shepherd AM; Hewick DS; Moreland TA; Stevenson IH
    Br J Clin Pharmacol; 1977 Jun; 4(3):315-20. PubMed ID: 901699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin K-dependent blood clotting changes in female rats treated with oestrogens.
    Hart JE
    Thromb Haemost; 1987 Jun; 57(3):273-7. PubMed ID: 2821645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients.
    Speeckaert MM; Devreese KM; Vanholder RC; Dhondt A
    Nephrol Dial Transplant; 2013 Dec; 28(12):3090-5. PubMed ID: 24021678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring of antivitamin K-dependent anticoagulation in rodents - Towards an evolution of the methodology to detect resistance in rodents.
    Lefebvre S; Hascoët C; Damin-Pernik M; Rannou B; Benoit E; Lattard V
    Pestic Biochem Physiol; 2017 May; 138():29-36. PubMed ID: 28456301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.